Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 124 posts
August 25, 2020 | Infographics
CBPartners lists the top 10 long-term trends and implications of COVID-19 on the biopharma industry as biopharma leaders prepare for a post-COVID-19 world.
August 5, 2020 | Blogs
Since its inception over 30 years ago, the 340B drug pricing program policy has evolved allowing for unprecedented expansion and influence. With this it has also become highly contested, especially in recent years as more legislation has been put forward to close 340B loopholes.
August 5, 2020 | Infographics
July 24, 2020 | News
In solidarity with the BLM movement, and as a firm committed to inclusivity, diversity, and a safe environment for all, CBPartners donated $25,000 cumulatively to Campaign Zero and Know Your Rights on behalf of everyone at the firm.